Publicaciones en las que colabora con María Blanco Prieto (30)

2021

  1. Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction

    Acta Biomaterialia, Vol. 126, pp. 394-407

  2. Optimization of a GDNF production method based on Semliki Forest virus vector

    European Journal of Pharmaceutical Sciences, Vol. 159

2019

  1. Long-term engraftment of human cardiomyocytes combined with biodegradable microparticles induces heart repair

    Journal of Pharmacology and Experimental Therapeutics, Vol. 370, Núm. 3, pp. 761-771

2016

  1. Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys

    Biomaterials, Vol. 110, pp. 11-23

  2. Catheter-based intramyocardial injection of FGF1 or NRG1-loaded MPs improves cardiac function in a preclinical model of ischemia-reperfusion

    Scientific Reports, Vol. 6

2015

  1. Lipid nanosystems enhance the bioavailability and the therapeutic efficacy of FTY720 in acute myeloid leukemia

    Journal of Biomedical Nanotechnology, Vol. 11, Núm. 4, pp. 691-701

2014

  1. Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration

    Journal of Controlled Release, Vol. 173, Núm. 1, pp. 132-139

  2. Effect of FTY720 on the SET-PP2A complex in acute myeloid leukemia; SET binding drugs have antagonistic activity

    Leukemia

  3. Vascular endothelial growth factor-loaded injectable hydrogel enhances plasticity in the injured spinal cord

    Journal of Biomedical Materials Research - Part A, Vol. 102, Núm. 7, pp. 2345-2355

2013

  1. A simple and efficient method for the production of human glycosylated glial cell line-derived neurotrophic factor using a Semliki Forest virus expression system

    International Journal of Pharmaceutics, Vol. 440, Núm. 1, pp. 19-26

  2. Cardiac regeneration with stem cells

    Regenerative Medicine and Cell Therapy (Humana Press Inc.), pp. 65-112

  3. Drug development in Parkinson's disease: From emerging molecules to innovative drug delivery systems

    Maturitas, Vol. 76, Núm. 3, pp. 272-278

  4. Edelfosine lipid nanosystems overcome drug resistance in leukemic cell lines

    Cancer Letters, Vol. 334, Núm. 2, pp. 302-310

  5. Injectable alginate hydrogel loaded with GDNF promotes functional recovery in a hemisection model of spinal cord injury

    International Journal of Pharmaceutics, Vol. 455, Núm. 1-2, pp. 148-158

  6. PEGylated-PLGA microparticles containing VEGF for long term drug delivery

    International Journal of Pharmaceutics, Vol. 440, Núm. 1, pp. 13-18

2012

  1. Angiogenic therapy for cardiac repair based on protein delivery systems

    Heart Failure Reviews, Vol. 17, Núm. 3, pp. 449-473

  2. Brain drug delivery systems for neurodegenerative disorders

    Current Pharmaceutical Biotechnology, Vol. 13, Núm. 12, pp. 2388-2402

  3. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia

    Leukemia, Vol. 26, Núm. 7, pp. 1517-1526

  4. Vascular endothelial growth factor-delivery systems for cardiac repair: An overview

    Theranostics, Vol. 2, Núm. 6, pp. 541-552

2011

  1. Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson's disease

    Movement Disorders, Vol. 26, Núm. 10, pp. 1943-1947